Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens

Abstract excerpt

The HIV-1 envelope glycoprotein spike is the target of neutralizing antibody attack, and hence represents the only relevant viral antigen for antibody-based vaccine design. Various approaches have been attempted to recapitulate Env in membrane-anchored and soluble forms, and these will be discussed here in the context of recent successes and challenges still to be overcome.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV Research and Treatment
• Share to Immunotherapy and Immune Responses
• Share to Monoclonal and Polyclonal Antibodies Research